Oracle acquires Phase Forward

Oracle acquires Phase Forward

Summary: Oracle has bought the healthcare and life sciences software company, paying at 30-percent premium for its services

SHARE:
TOPICS: Tech Industry
0

Oracle said on Friday it will acquire Phase Forward, a healthcare and life sciences software provider, for $685m. Oracle, which is intensely focused on vertical-specific applications, said the deal will bolster its healthcare software line-up.

Phase Forward's software is delivered as a service. The company's Integrated Clinical Research Suite manages the drug submission development and safety processes from trial to submission to the Food and Drug Administration and other authorities.

Oracle paid $17 (£11) a share for Phase Forward, which closed on Thursday at $13.08 a share, marking the deal as a 30-percent premium. The purchase will help position Oracle for the healthcare IT boom. Phase Forward was showing some strong growth. In 2009, Phase Forward delivered revenue of $213.3m, up 25 percent from 2008. Net income was $8m.

For more on this story, see Oracle buys Phase Forward; Bolsters healthcare software on ZDNet.com

Topic: Tech Industry

Kick off your day with ZDNet's daily email newsletter. It's the freshest tech news and opinion, served hot. Get it.

Talkback

0 comments
Log in or register to start the discussion